Scaling up access to seasonal malaria chemoprevention in the Sahel

Diego Moroso, Project Director for ACCESS-SMC, presented the feasibility, safety and effectiveness of seasonal malaria chemoprevention (SMC) at scale at MIM 2018. There is an estimated gap of 12 to 18 million children who could benefit from SMC, but who are not currently included in SMC programmes. It is urgent to close this gap and maximize the impact of this intervention. Malaria can be prevented, and in the Sahel and sub-Sahel regions of Africa SMC can make an important contribution.

Click here to download

Country: Mali | The Gambia | Guinea | Nigeria | Niger | Chad | Burkina Faso

Issues: Malaria